Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer.
acute myeloid leukemia
etoposide
small cell lung cancer
topoisomerase II inhibitors
toxicity
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
13
06
2018
revised:
09
10
2018
accepted:
31
10
2018
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
19
1
2019
Statut:
epublish
Résumé
We experienced therapy-related acute myeloid leukemia (t-AML) in a patient with extensive disease-small cell lung cancer (ED-SCLC). This case is rare and has educational message because ED-SCLC has a poor prognosis and often cannot survive until developing therapy related hematological malignancy. Furthermore this case had unique chromosomal abnormalities. With recent advances in chemotherapy and radiotherapy, the prognosis of lung cancer has improved, while t-AML has been increasing in frequency.
Identifiants
pubmed: 30656018
doi: 10.1002/ccr3.1931
pii: CCR31931
pmc: PMC6332741
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100-103Références
Cancer Treat Rev. 2000 Oct;26(5):377-91
pubmed: 11006138
Haematologica. 1999 Oct;84(10):937-45
pubmed: 10509043
J Clin Oncol. 1986 Dec;4(12):1748-57
pubmed: 3783201
Cancer Res Treat. 2019 Jan;51(1):119-127
pubmed: 29529858
J Clin Oncol. 1998 Oct;16(10):3386-91
pubmed: 9779717
Br J Haematol. 2000 Apr;109(1):13-23
pubmed: 10848777
Clin Case Rep. 2018 Nov 19;7(1):100-103
pubmed: 30656018
Lancet. 2000 Dec 23-30;356(9248):2158
pubmed: 11191547
Ann Oncol. 1992 Feb;3(2):107-11
pubmed: 1318741
Blood. 2013 Apr 11;121(15):2996-3004
pubmed: 23412096